Zhou Yaqiong, Wang Dan, Jiang Licheng, Ran Fei, Chen Sichao, Zhou Peng, Wang Peijian
Cardiology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Cardiology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China
BMJ Open. 2020 Dec 31;10(12):e038489. doi: 10.1136/bmjopen-2020-038489.
Accurate subtype classification in primary aldosteronism (PA) is critical in assessing the optimal treatment options. This study aimed to evaluate the diagnostic accuracy of adrenal imaging for unilateral PA classification.
Systematic searches of PubMed, EMBASE and the Cochrane databases were performed from 1 January 2000 to 1 February 2020, for all studies that used CT or MRI in determining unilateral PA and validated the results against invasive adrenal vein sampling (AVS). Summary diagnostic accuracies were assessed using a bivariate random-effects model. Subgroup analyses, meta-regression and sensitivity analysis were performed to explore the possible sources of heterogeneity.
A total of 25 studies, involving a total of 4669 subjects, were identified. The overall analysis revealed a pooled sensitivity of 68% (95% CI: 61% to 74%) and specificity of 57% (95% CI 50% to 65%) for CT/MRI in identifying unilateral PA. Sensitivity was higher in the contrast-enhanced (CT) group versus the traditional CT group (77% (95% CI 66% to 85%) vs 58% (95% CI 50% to 66%). Subgroup analysis stratified by screening test for PA showed that the sensitivity of the aldosterone-to-renin ratio (ARR) group was higher than that of the non-ARR group (78% (95% CI 69% to 84%) vs 66% (95% CI 58% to 72%)). The diagnostic accuracy of PA patients aged ≤40 years was reported in four studies, and the overall sensitivity was 71%, with 79% specificity. Meta-regression revealed a significant impact of sample size on sensitivity and of age and study quality on specificity.
CT/MRI is not a reliable alternative to invasive AVS without excellent sensitivity or specificity for correctly identifying unilateral PA. Even in young patients (≤40 years), 21% of patients would have undergone unnecessary adrenalectomy based on imaging results alone.
原发性醛固酮增多症(PA)的准确亚型分类对于评估最佳治疗方案至关重要。本研究旨在评估肾上腺成像对单侧PA分类的诊断准确性。
对2000年1月1日至2020年2月1日期间的PubMed、EMBASE和Cochrane数据库进行系统检索,查找所有使用CT或MRI确定单侧PA并通过侵入性肾上腺静脉采样(AVS)验证结果的研究。使用双变量随机效应模型评估汇总诊断准确性。进行亚组分析、meta回归和敏感性分析以探索异质性的可能来源。
共纳入25项研究,涉及4669名受试者。总体分析显示,CT/MRI识别单侧PA的合并敏感性为68%(95%CI:61%至74%),特异性为57%(95%CI 50%至65%)。对比增强CT组的敏感性高于传统CT组(77%(95%CI 66%至85%)对58%(95%CI 50%至66%))。按PA筛查试验分层的亚组分析显示,醛固酮与肾素比值(ARR)组的敏感性高于非ARR组(78%(95%CI 69%至84%)对66%(95%CI 58%至72%))。四项研究报告了年龄≤40岁的PA患者的诊断准确性,总体敏感性为71%,特异性为79%。Meta回归显示样本量对敏感性有显著影响,年龄和研究质量对特异性有显著影响。
CT/MRI并非侵入性AVS的可靠替代方法,在正确识别单侧PA方面缺乏出色的敏感性或特异性。即使在年轻患者(≤40岁)中,仅根据影像学结果,21%的患者可能会接受不必要的肾上腺切除术。